Results
2683
Stocks with high levels of insider buying the past 3 months and good analyst coverage.
2,683 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
JNJ | US$152.89 | 4.0% | -4.1% | US$353.5b | US$167.84 | PE26.2x | E8.4% | 3.2% | Pharmaceuticals & Biotech | ||
AZN | UK£111.70 | 1.1% | 5.5% | UK£173.4b | UK£139.09 | PE33.1x | E16.9% | 2.0% | Pharmaceuticals & Biotech | ||
HSBA | UK£8.24 | -0.2% | 32.7% | UK£145.0b | UK£8.67 | PB0.9x | E-1.3% | 6.0% | Banks | ||
CBA | AU$159.28 | 2.0% | 37.3% | AU$266.3b | AU$100.82 | PB3.6x | E4.4% | 2.9% | Banks | ||
LOW | US$268.42 | 2.8% | 26.7% | US$148.1b | US$282.24 | PE22.2x | E5.9% | 1.7% | Retail | ||
PFE | US$26.86 | 2.1% | -2.3% | US$147.9b | US$31.18 | PE35.6x | E8.5% | 6.4% | Pharmaceuticals & Biotech | ||
COP | US$102.69 | -3.0% | -8.0% | US$131.7b | US$131.90 | PE13.4x | E1.6% | 3.6% | Energy | ||
BHP | AU$39.48 | -2.8% | -16.1% | AU$200.3b | AU$44.32 | PE15.8x | E6.4% | 5.9% | Materials | ||
TD | CA$82.63 | 0.3% | -0.2% | CA$143.8b | CA$85.86 | PB1.3x | E10.8% | 5.1% | Banks | ||
INVE A | SEK 312.10 | -0.5% | 27.6% | SEK 952.3b | SEK 331.50 | PE8.4x | E-48.3% | 1.7% | Diversified Financials | ||
BP. | UK£4.18 | -2.0% | -10.7% | UK£65.6b | UK£4.80 | PE30.1x | E23.6% | 5.9% | Energy | ||
ATCO A | SEK 180.40 | -3.1% | 9.0% | SEK 880.8b | SEK 191.09 | PE30.6x | E7.9% | 1.6% | Capital Goods | ||
BREN | Rp9,600.00 | -2.5% | 91.0% | Rp1284.3t | n/a | PE728.5x | n/a | 0.04% | Utilities | ||
ITW | US$264.42 | 3.1% | 0.09% | US$76.7b | US$264.31 | PE22.6x | E1.1% | 2.3% | Capital Goods | ||
NAB | AU$39.82 | 2.4% | 23.9% | AU$122.1b | AU$33.91 | PB2x | E2.0% | 4.3% | Banks | ||
1299 | HK$54.25 | -2.3% | -12.5% | HK$580.6b | HK$93.05 | PE15.4x | E13.7% | 3.0% | Insurance | ||
WBC | AU$33.40 | 2.0% | 40.2% | AU$114.5b | AU$28.56 | PB1.6x | E-0.02% | 4.6% | Banks | ||
GSK | UK£13.88 | 2.1% | -9.8% | UK£57.2b | UK£17.94 | PE22.5x | E20.8% | 4.2% | Pharmaceuticals & Biotech | ||
DGE | UK£24.95 | 2.7% | -12.8% | UK£55.4b | UK£26.42 | PE17.8x | E5.0% | 3.3% | Food, Beverage & Tobacco | ||
CRH | US$99.03 | 1.3% | 40.0% | US$68.6b | US$113.54 | PE19.4x | E9.5% | 1.4% | Materials | ||
KMI | US$27.46 | -9.4% | 58.1% | US$67.2b | US$29.42 | PE23.3x | E11.3% | 4.2% | Energy | ||
CNR | CA$153.38 | 3.5% | -7.9% | CA$95.2b | CA$171.24 | PE17.8x | E3.9% | 2.2% | Transportation | ||
FDX | US$281.53 | 2.3% | 13.5% | US$65.8b | US$323.52 | PE17.5x | E12.9% | 2.0% | Transportation | ||
SPG | US$176.70 | 1.5% | 24.7% | US$65.4b | US$186.53 | PB21.6x | E0.4% | 4.8% | Real Estate |